ISPOR Announces New CEO

Published Mar 13, 2023

Board Has Appointed Rob Abbott to Lead the Society

Lawrenceville, NJ, USA—March 13, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that its Board of Directors has appointed Rob Abbott as the Society’s new CEO and executive director after an extensive search process. Mr Abbott is assuming the role of ISPOR’s CEO today, succeeding Nancy S. Berg who is retiring.

Mr Abbott is a highly accomplished, visionary leader with more than 20 years’ experience providing executive-level strategic and operational leadership in businesses, nongovernmental organizations (NGOs), government environments, as well as professional societies and associations. Most recently, he served as executive director and CEO of Health Technology Assessment International, a global nonprofit society focused on health technology assessment (HTA). He is recognized for his knowledge in HTA, strategy, and stakeholder relations. He has successfully guided a number of organizations through their transformation and growth. He is also a pioneering social responsibility thinker and advisor who has authored 2 books and numerous articles on the nature of business and society. Mr Abbott holds an undergraduate honors degree from the University of Victoria and graduate degrees from the University of Toronto. Additionally, he holds professional designations as both a management consultant and an ICF-accredited coach.

"After a rigorous and comprehensive executive search process, I could not be more pleased to announce Rob Abbott as ISPOR's next CEO!," says ISPOR President Jan Hansen. "Rob is uniquely qualified—his bold vision, leadership experience, team-based orientation, and commitment to growth, make him the ‘right choice’ in further accelerating ISPOR's impact and advancing ISPOR's mission to improve healthcare decisions. Of course, we are certainly grateful to Nancy Berg for her many accomplishments and contributions. Rob will no doubt build upon her legacy, as the ‘next chapter’ in ISPOR's evolution unfolds. It is indeed with great pleasure that I welcome Rob to the ISPOR organization!"

“It’s a privilege and an honor to succeed Nancy Berg as CEO of ISPOR,” stated Mr Abbott. ”The organization has an enviable reputation—and impact—globally. I look forward to working with the Board, staff, and members of ISPOR to help ensure that the organization continues to grow in its reach, its impact, and its membership. In particular, I want to leverage our collective influence to make HEOR essential to healthcare decision makers across the globe.”


ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

Proposed Drug Pricing Policy Would Save Medicare Between $1 Billion and $2.1 Billion Annually

Sep 5, 2023

Value in Health, the official journal of ISPOR, announced the publication of a report that identifies expensive Medicare Part B drugs with low added therapeutic benefit and models a reimbursement policy for them based on domestic reference pricing.

ISPOR Announces New Chief Science Officer

Aug 28, 2023

ISPOR announced that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke, PhD, will be retiring.

Global Multistakeholder Panel Provides First-of-its-Kind Guidance on Assessing the Value of Biosimilar Drugs

Aug 15, 2023

Value in Health published a new ISPOR Report that provides an overview of gaps and challenges in the value assessment of biosimilars and identifying potential approaches to address them. The report was published in the August 2023 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now